Bridging the gap between bioinformatics and the clinical and public health microbiology
laboratory: An ISO-accredited genomics workflow for antimicrobial resistance
Realising the promise of genomics to revolutionise routine AMR diagnosis and surveillance has
been a long-standing challenge in clinical and public health microbiology. We have directly
addressed this issue by creating and validating abritAMR, an ISO-accredited bioinformatics
platform for genomics-based bacterial AMR gene detection. abritAMR utilises the NCBI
AMRFinderPlus for detection of AMR genes and mutations, with additional features to classify
AMR determinants into an antibiotic class. We validated abritAMR by comparing with multiplex
PCR or gold-standard reference genomes, together representing 1500 different bacteria across
29 genera and covering 415 antibiotic resistance alleles.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!